Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Preprint
- 22 February 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Despite initial responses to hormone treatment, metastatic prostate cancer invariably evolves to a lethal state. To characterize the intra-patient relationships of metastases that evade treatment, we performed genome-wide copy number profiling and bespoke approaches targeting the androgen receptor (AR) on 142 metastatic regions from 10 organs harvested post-mortem from nine men who died from prostate cancer. We identified diverse and patient-unique alterations clustering around the AR in metastases from every patient with evidence of independent acquisition of related genomic changes within an individual and, in some patients, the co-existence of AR-neutral clones. Using the genomic boundaries of pan-autosome copy number change, we confirmed a common clone of origin across metastases and diagnostic biopsies; and identified in individual patients, clusters of metastases occupied by dominant clones with diverged autosomal copy number alterations and cluster-specific AR gene architectures. Copy number boundaries identified treatment-selected clones with distinct lethal trajectories.Keywords
All Related Versions
- Version 1, 2023-02-22, Research Square
- Published version: Nature Communications, 14 (1), 1.
This publication has 48 references indexed in Scilit:
- Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trialThe Lancet, 2018
- Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyEuropean Urology, 2018
- A One-Penny Imputed Genome from Next-Generation Reference PanelsThe American Journal of Human Genetics, 2018
- Genomic Hallmarks and Structural Variation in Metastatic Prostate CancerCell, 2018
- A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerCell, 2018
- Universal Patterns of Selection in Cancer and Somatic TissuesCell, 2017
- Integrative Clinical Genomics of Advanced Prostate CancerCell, 2015
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsCancer Cell, 2006
- Silhouettes: A graphical aid to the interpretation and validation of cluster analysisJournal of Computational and Applied Mathematics, 1987